SMV will exhibit at its first RSNA conference since the nuclearmedicine vendor was formed through the merger of Sopha Medicaland Summit Nuclear (SCAN 6/21/95). SMV has renamed the Sopha andSummit product lines, giving them the prefix "Vision. Among
SMV will exhibit at its first RSNA conference since the nuclearmedicine vendor was formed through the merger of Sopha Medicaland Summit Nuclear (SCAN 6/21/95). SMV has renamed the Sopha andSummit product lines, giving them the prefix "Vision.
Among the new technologies SMV will emphasize is coincidencedetection, to be shown as a work-in-progress on both the DST-XLand the FX-80 dual-head cameras, according to Lonnie Mixon, directorof marketing.
SMV will also highlight Restore, a resolution recovery algorithmthat corrects for geometric distortion caused by collimators inSPECT studies. The technique can be used with SMV's transmissionattenuation correction (TAC) protocol.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.